Latest news for Centogene (OTC:CNTGF) Stock

Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.

Centogene NV

Centogene (CNTGF) has released an update. Centogene GmbH has entered into a management leasing contract with Atreus Interim Management GmbH to appo...

Centogene Appoints New CRO for Restructuring

Centogene (CNTGF) has released an update. Centogene N.V. has announced that EY GmbH will not continue as the company's auditor for the fiscal year ...

Centogene N.V. Seeks New Auditor for 2024

Centogene (CNTGF) has released an update. Centogene has announced compelling findings in ‘The Lancet Neurology' from its Rostock International Park...

Centogene Links Gene Mutation to Parkinson's Disease

Centogene (CNTGF) has released an update. Centogene N.V. has announced the postponement of the resignations of Peer Schatz and Mary Sheahan from it...

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Centogene

News

Latest news for Centogene (OTC:CNTGF) Stock